Immunovant, Inc.

IMVT · NASDAQ
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$713,971$635,365$376,532$493,817
Short-Term Investments$0$0$0$0
Receivables$2,511$5,503$885$12,861
Inventory$0$0$0$0
Other Curr. Assets$51,180$24,902$26,916$6,253
Total Curr. Assets$767,662$665,770$404,333$512,931
Property Plant & Equip (Net)$942$595$1,505$2,633
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$347$0$0
Other NC Assets$7,618$0$0$0
Total NC Assets$8,560$942$1,505$2,633
Other Assets$0$0$0$0
Total Assets$776,222$666,712$405,838$515,564
Liabilities
Payables$17,656$7,155$1,353$18,629
Short-Term Debt$98$138$1,173$1,145
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$51,021$41,315$40,771$24,746
Total Curr. Liab.$68,775$48,608$43,297$44,520
LT Debt$0$0$47$1,219
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$347$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$347$47$1,219
Other Liabilities$0$0$0$0
Cap. Leases$98$0$1,220$2,364
Total Liabilities$68,775$48,955$43,344$45,739
Equity
Pref Stock$0$0$0$0
Common Stock$16$14$13$12
Retained Earnings-$1,239,523-$825,683-$566,347-$355,387
AOCI$1,459$1,908$852$404
Other Equity$1,945,495$1,441,518$927,976$824,796
Total Equity$707,447$617,757$362,494$469,825
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$776,222$666,712$405,838$515,564
Net Debt-$713,873-$635,227-$375,312-$491,453
Immunovant, Inc. (IMVT) Financial Statements & Key Stats | AlphaPilot